nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—metabolic syndrome X	0.91	1	CbGaD
Equilin—HSD17B1—The canonical retinoid cycle in rods (twilight vision)—RBP4—metabolic syndrome X	0.0116	0.141	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—HSD11B1—metabolic syndrome X	0.0111	0.135	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—RBP4—metabolic syndrome X	0.00361	0.0438	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOC3—metabolic syndrome X	0.0032	0.0388	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOB—metabolic syndrome X	0.00206	0.0249	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—LPL—metabolic syndrome X	0.00197	0.0238	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOE—metabolic syndrome X	0.00165	0.02	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOA1—metabolic syndrome X	0.00163	0.0197	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.0015	0.0182	CbGpPWpGaD
Equilin—Estriol—SHBG—metabolic syndrome X	0.00136	0.192	CrCbGaD
Equilin—Ethinyl Estradiol—NR1I2—metabolic syndrome X	0.00129	0.183	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.0012	0.0146	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00114	0.0138	CbGpPWpGaD
Equilin—Estropipate—SHBG—metabolic syndrome X	0.00104	0.147	CrCbGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—metabolic syndrome X	0.00101	0.0122	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000991	0.012	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000968	0.0117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000938	0.0114	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000928	0.0112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000863	0.0105	CbGpPWpGaD
Equilin—Estradiol—NR1I2—metabolic syndrome X	0.000851	0.121	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000769	0.00932	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000765	0.00926	CbGpPWpGaD
Equilin—HSD17B1—Disease—G6PC2—metabolic syndrome X	0.000751	0.0091	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FMO3—metabolic syndrome X	0.000751	0.0091	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000742	0.00899	CbGpPWpGaD
Equilin—Ethinyl Estradiol—SHBG—metabolic syndrome X	0.00074	0.105	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000711	0.00861	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.00069	0.00836	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000671	0.00813	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EPHX2—metabolic syndrome X	0.000669	0.00811	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MLXIPL—metabolic syndrome X	0.000669	0.00811	CbGpPWpGaD
Equilin—Estrone—SHBG—metabolic syndrome X	0.000645	0.0914	CrCbGaD
Equilin—HSD17B1—Metabolism—G6PC2—metabolic syndrome X	0.000629	0.00762	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000598	0.00725	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000579	0.00702	CbGpPWpGaD
Equilin—HSD17B1—Disease—G6PD—metabolic syndrome X	0.00054	0.00654	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FABP4—metabolic syndrome X	0.000535	0.00648	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC3—metabolic syndrome X	0.000527	0.00638	CbGpPWpGaD
Equilin—HSD17B1—Disease—GCKR—metabolic syndrome X	0.000515	0.00624	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD11B1—metabolic syndrome X	0.000507	0.00614	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000492	0.00596	CbGpPWpGaD
Equilin—Estradiol—SHBG—metabolic syndrome X	0.000489	0.0693	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000478	0.00579	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000469	0.00569	CbGpPWpGaD
Equilin—HSD17B1—Disease—TRIB3—metabolic syndrome X	0.000459	0.00556	CbGpPWpGaD
Equilin—HSD17B1—Disease—RBP4—metabolic syndrome X	0.000459	0.00556	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—G6PD—metabolic syndrome X	0.000452	0.00548	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000446	0.0054	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HDAC3—metabolic syndrome X	0.000441	0.00534	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPA—metabolic syndrome X	0.000431	0.00522	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCKR—metabolic syndrome X	0.000431	0.00522	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G6—metabolic syndrome X	0.000418	0.00506	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000415	0.00502	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA5—metabolic syndrome X	0.000413	0.00501	CbGpPWpGaD
Equilin—HSD17B1—Disease—NAMPT—metabolic syndrome X	0.000412	0.00499	CbGpPWpGaD
Equilin—HSD17B1—Disease—GCK—metabolic syndrome X	0.000409	0.00496	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOC3—metabolic syndrome X	0.000407	0.00492	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000402	0.00487	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000394	0.00477	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000389	0.00471	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TRIB3—metabolic syndrome X	0.000384	0.00466	CbGpPWpGaD
Equilin—HSD17B1—Disease—HMGA1—metabolic syndrome X	0.000374	0.00453	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000369	0.00447	CbGpPWpGaD
Equilin—HSD17B1—Disease—GOT2—metabolic syndrome X	0.000357	0.00432	CbGpPWpGaD
Equilin—HSD17B1—Disease—CYBA—metabolic syndrome X	0.000355	0.0043	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NAMPT—metabolic syndrome X	0.000345	0.00418	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000343	0.00415	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LIPC—metabolic syndrome X	0.000343	0.00415	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCK—metabolic syndrome X	0.000343	0.00415	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOC3—metabolic syndrome X	0.00034	0.00412	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CETP—metabolic syndrome X	0.000331	0.004	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00033	0.004	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RBP4—metabolic syndrome X	0.000321	0.00389	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000321	0.00389	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A4—metabolic syndrome X	0.000318	0.00385	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SCARB1—metabolic syndrome X	0.000317	0.00383	CbGpPWpGaD
Equilin—Estropipate—ALB—metabolic syndrome X	0.000312	0.0442	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000308	0.00373	CbGpPWpGaD
Equilin—HSD17B1—Disease—GOT1—metabolic syndrome X	0.000308	0.00373	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SREBF1—metabolic syndrome X	0.000307	0.00372	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMGCR—metabolic syndrome X	0.000299	0.00362	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT2—metabolic syndrome X	0.000299	0.00362	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOC3—metabolic syndrome X	0.000285	0.00345	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.00027	0.00327	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCA1—metabolic syndrome X	0.000266	0.00323	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A4—metabolic syndrome X	0.000266	0.00323	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOB—metabolic syndrome X	0.000261	0.00317	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GGT1—metabolic syndrome X	0.000258	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT1—metabolic syndrome X	0.000258	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000257	0.00311	CbGpPWpGaD
Equilin—HSD17B1—Disease—LPL—metabolic syndrome X	0.00025	0.00302	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CYBA—metabolic syndrome X	0.000249	0.00301	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GHRL—metabolic syndrome X	0.000244	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR1—metabolic syndrome X	0.000231	0.00279	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOB—metabolic syndrome X	0.000219	0.00265	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G4A—metabolic syndrome X	0.000213	0.00258	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—metabolic syndrome X	0.000209	0.00253	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPL—metabolic syndrome X	0.000209	0.00253	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOA1—metabolic syndrome X	0.000207	0.00251	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CD36—metabolic syndrome X	0.000199	0.00241	CbGpPWpGaD
Equilin—Estrone—ALB—metabolic syndrome X	0.000194	0.0275	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—IGF2—metabolic syndrome X	0.000189	0.00228	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS1—metabolic syndrome X	0.000187	0.00226	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARA—metabolic syndrome X	0.000185	0.00224	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOB—metabolic syndrome X	0.000183	0.00222	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AGT—metabolic syndrome X	0.000179	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL5—metabolic syndrome X	0.000179	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Disease—INS—metabolic syndrome X	0.000179	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000178	0.00216	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—metabolic syndrome X	0.000175	0.00212	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPL—metabolic syndrome X	0.000175	0.00212	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA1—metabolic syndrome X	0.000173	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—metabolic syndrome X	0.000164	0.00199	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—metabolic syndrome X	0.000157	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—metabolic syndrome X	0.000153	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INS—metabolic syndrome X	0.00015	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGT—metabolic syndrome X	0.00015	0.00181	CbGpPWpGaD
Equilin—Estradiol—ALB—metabolic syndrome X	0.000147	0.0208	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—APOE—metabolic syndrome X	0.000147	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—metabolic syndrome X	0.000147	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOA1—metabolic syndrome X	0.000145	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—metabolic syndrome X	0.000143	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—metabolic syndrome X	0.000137	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—metabolic syndrome X	0.000131	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS1—metabolic syndrome X	0.000131	0.00158	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INS—metabolic syndrome X	0.000125	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—metabolic syndrome X	0.000123	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—metabolic syndrome X	0.000121	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—metabolic syndrome X	0.00012	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000115	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—metabolic syndrome X	0.00011	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—metabolic syndrome X	0.000104	0.00126	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—metabolic syndrome X	7.81e-05	0.000946	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—metabolic syndrome X	7.26e-05	0.000879	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—metabolic syndrome X	7.21e-05	0.000873	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—metabolic syndrome X	6.04e-05	0.000731	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—metabolic syndrome X	5.47e-05	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—metabolic syndrome X	5.05e-05	0.000611	CbGpPWpGaD
